emirates7 - Gilead Sciences, a research-based biopharmaceutical company, has announced the opening of new offices in Dubai as part of its efforts to grow its regional footprint and expand its portfolio across areas such as COVID-19 and oncology.

The launch event saw the attendance of several dignitaries including Dr. Amin Hussein Al-Amiri, Assistant Under-Secretary for the Health Regulation Sector, Ministry of Health and Prevention; Helal Saeed Al Marri, Director-General of the Dubai Department of Economy and Tourism; Prof. Alawi Alsheikh-Ali, Deputy Director-General of Dubai Health Authority (DHA); Dr. Younis Kazim, CEO of Dubai Healthcare Corporation, and Dr. Ali Al Sayed, Director of the Pharmaceutical Services Department at DHA.

The new offices of Gilead Sciences were designed to reflect Dubai’s status as a global centre of business further to the cultural diversity of the UAE and surrounding Gulf region.

Dr. Jacopo Andreose, Senior Vice President, Intercontinental and Global Patient Solutions at Gilead Sciences, said, "The pharmaceutical sector in the UAE is benefitting from a steady rise in population and net income and the roll-out of the mandatory health insurance scheme. The healthcare industry is marked by continued improvement and strategic investments in high-quality medical services by the leadership. We are keen on growing our presence in the UAE and wider region and will continue to invest in infrastructure and talent to best capitalise on these positive trends and to deliver upon the promise of our bold and transformative science."

Frederico Silva, General Manager, Gilead Sciences Middle East, added, "Committed to grow as an employer of choice, our investments in state-of-the-art spaces to house our talent is reflective of our core values that guide our steadfast mission of developing and delivering innovative therapies within HIV, cancer, COVID-19 and viral hepatitis. In our vision to a healthier world for all people, delivering innovative medicines that aim to prevent, treat and cure life-threatening diseases, we are guided by a philosophy that by investing in our employee experience further we are able to better serve our patient communities."